Skip to main content
Premium Trial:

Request an Annual Quote

Xceleron Extends Supplier Agreement with GlaxoSmithKline

NEW YORK, Oct. 24 (GenomeWeb News) GlaxoSmithKline has extended its supplier agreement with Xceleron for three years, Xceleron said today.


Xceleron, specializing in accelerator mass spectrometry (AMS) services, said that it will support GlaxoSmithKline's bioanalytical AMS program specifically for human metabolite profiling and obtaining mass balance data.


One of the organizations behind Xceleron's founding in 1997, GlaxoSmithKline has been a client since that time, Xceleron said.


Xceleron will also provide GSK with consulting services to develop AMS analytical processes, problem-solving, and back-up analysis.


Financial terms of the agreement were not disclosed.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.